Stay updated on Botensilimab for Advanced Melanoma Clinical Trial
Sign up to get notified when there's something new on the Botensilimab for Advanced Melanoma Clinical Trial page.

Latest updates to the Botensilimab for Advanced Melanoma Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoChange DetectedThe History page shows a new revision entry v3.4.2 and removes v3.4.1, updating the change log. No substantive changes to trial data or status are observed; To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check19 days agoChange DetectedNew revision entry v3.4.1 added to the History, and the previous revision v3.4.0 was removed. This updates the page's version history to reflect the latest change.SummaryDifference0.1%

- Check33 days agoChange DetectedGlossary toggle controls (Show glossary / Hide glossary) and color-coded change highlights (green for additions, red for deletions) were added to the study history page, with a new revision label v3.4.0 dated 2026-01-16. The previous revision shows v3.3.4 dated 2025-03-10 with No FEAR Act data. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference2%

- Check41 days agoChange DetectedThe page history now includes a new revision label, v3.3.4, indicating an updated version. The previous revision, v3.3.3, remains accessible in the history.SummaryDifference0.1%

- Check69 days agoChange DetectedA new revision entry 'Revision: v3.3.3' was added to the study record history. The 'HHS Vulnerability Disclosure' link and the older 'Revision: v3.3.2' entry were removed from the page.SummaryDifference0.2%

- Check90 days agoChange DetectedA new revision entry v3.3.2 was added to the Study Record Version history, and revision v3.2.0 was removed from the list. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to Botensilimab for Advanced Melanoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Botensilimab for Advanced Melanoma Clinical Trial page.